newsfilter
← Latest News
GlobeNewswire·

Affimed to Report Third Quarter 2024 Financial Results & Corporate Update on November 14, 2024

MANNHEIM, Germany, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (NASDAQ:AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it